Page 5 - Wavewriter Alpha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BSX earnings call for the period ending September 30, 2021.

Digital Health Innovation Award: MedBridge Best Hospital Technology Implementation: Hicuity Health Best Health Network Technology Implementation: iMedX Best Overall MedTech Software: NantHealth, Eviti Connect  Best Overall MedTech Company: Convey Health Best Overall Digital Health Company: Doctor On Demand Clinical and Health Administration Best Compliance Solution: HOTB Software Best Compliance Management Solution Provider: MedTrainer Best Patient Registration & Scheduling Solution: Kyruus, ProviderMatch for Consumers Best Computerized Decision Support Solution: Elsevier ClinicalPath Best O...

MedTech Breakthrough Honors Standout Digital Health and Medical Technology Innovation in 2021 MedTech Breakthrough Awards Program Share Article Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies "In our 5th annual MedTech Breakthrough Awards program we are thrilled to recognize the digital health leaders that doubled down, pivoted and accelerated MedTech innovation in a time of need to build a new health system that better supports the entire care journey” LOS ANGELES (PRWEB) May 06,...

Boston Scientific Announces Results For First Quarter 2021 News provided by Share this article Share this article MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This represents growth of 8.2 percent on a reported basis, 5.6 percent on an operational 1 basis and 5.9 percent on an organic 2 basis, all compared to the prior year period. The company reported GAAP net income available to common stockholders of $327 million or $0.23 per share (EPS), compared to GAAP net income of $...

Boston Scientific Announces Results For Fourth Quarter And Full Year 2020 News provided by Share this article Share this article MARLBOROUGH, Mass., Feb. 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) percent on a reported basis, (8.3) percent on an operational 1 basis and (8.0) percent on an organic 2 basis, all compared to the prior year period. Included within organic results is a negative 370 basis point impact associated with the conversion of U.S. WATCHMAN™ cu...